|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/705 | |
| A61K 38/19 | |||
| A61K 39/395 | |||
| G01N 33/50 | |||
| C12Q 1/68 | |||
| A61P 35/04 | |||
| C07K 16/28 | |||
| G01N 33/574 |
| (11) | Number of the document | 3177641 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15794549.4 |
| Date of filing the European patent application | 2015-11-12 | |
| (97) | Date of publication of the European application | 2017-06-14 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/076404 |
| Date | 2015-11-12 |
| (87) | Number | WO 2016/075221 |
| Date | 2016-05-19 |
| (30) | Number | Date | Country code |
| 14193179 | 2014-11-14 | EP |
| (72) |
SALIH, Helmut, DE
GROSSE-HOVEST, Ludger, DE
HERRMANN, Andreas, CH
KOPP, Hans-Georg, DE
MAURER, Stefanie, DE
|
| (73) |
Probiocon GmbH,
Moosackerweg 6, 4148 Pfeffingen,
CH
|
| (54) | RANKL-SPECIFIC AGENT FOR TREATING METASTATIC DISEASE |
| RANKL-SPECIFIC AGENT FOR TREATING METASTATIC DISEASE |